Lindsey Marwood
PhD researcher affiliated with Compass Pathfinder Ltd (Compass Pathways plc), London, United Kingdom
Data updated
Research Footprint
Lindsey Marwood appears in 7 tracked papers (2022–2026), most studied alongside Psilocybin, across Depressive Disorders, Treatment-Resistant Depression (TRD) and Suicidality.
Most-cited paper: Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression (1057 citations).
Frequent co-authors: Guy Goodwin, Ekaterina Malievskaia and Joyce Tsai.
Background & Research
Lindsey Marwood is a researcher in psychiatry and psychopharmacology whose work has focused on treatment-resistant depression and psychedelic-assisted therapy. Their profile at King’s College London shows research interests spanning treatment-resistant depression, major depressive disorder, and psilocybin, and they are listed as affiliated with Compass Pathfinder Ltd in London.
Key Impact
Lindsey Marwood is a contributing researcher on multiple major psilocybin clinical studies in treatment-resistant depression, helping shape the evidence base on safety, antidepressant response, and the role of the psychedelic experience.
Collaboration Network
28 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Lindsey Marwood is associated with.